+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)- Product Image
Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)- Product Image
New

Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)

  • PDF Icon

    Report

  • 388 Pages
  • January 2025
  • Region: Global
  • iGATE Research
  • ID: 5390142
Description Jump to:

The global influenza vaccines market is projected to reach US$ 12.16 Billion by 2032, from US$ 7.60 Billion in 2024. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. According to data published by the World Health Organization (WHO) in 2023, around 3 to 5 million severe influenza cases were recorded, leading to 290,000 to 650,000 deaths across the globe. Several worldwide pharmacoeconomic studies have shown that vaccination can prevent about 50% of deaths from influenza-related complications in the elderly. The Centers for Disease Control and Prevention (CDC) recommends routine seasonal influenza vaccination for all individuals 6 months of age and older. 

The vast population base together with significantly low vaccination coverage in emerging markets, the introduction of new vaccines, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will drive the influenza vaccines market growth. Moreover, the increasing R&D investments by leading market players, such as Sanofi, CSL Limited, and GSK plc, for expanding manufacturing capabilities and focus on launching new vaccines will propel the market for influenza vaccines over the forecast period.

For instance, in March 2024, Cadila Pharmaceuticals, India launched Cadiflu Tetra Vaccine, an advanced quadrivalent influenza vaccine approved by the DCGI for adults and children.  Recently, in June 2024, Moderna, Inc. announced that its Phase 3 trial for mRNA-1083, an investigational combination vaccine targeting influenza and COVID-19, has successfully achieved its primary endpoints, demonstrating a stronger immune response compared to licensed comparator vaccines used in the study. 

Recent Developments

  • In December 2024, The US Food and Drug Administration has granted Fast Track designation to two Sanofi combination vaccine candidates to prevent influenza and COVID-19 infections in individuals 50 years of age and older.
  • In September 2024, Osivax and KM Biologics Co., Ltd., announced a license option agreement granting KM Biologics an exclusive license option to develop, manufacture and commercialize Osivax’s broad-spectrum “universal” influenza vaccine candidates for the Japanese market.
  • In July 2024, CSL Seqirus was selected by the Health Emergency Preparedness and Response Authority (HERA), part of the European Commission (EC), to provide 665,000 pre-pandemic vaccine doses for fifteen EU and EEA Member States as well as to the ""Union Civil Protection Mechanism"" (rescEU). 
  • In October 2023, BioNTech SE and Pfizer Inc. announced positive results from a Phase 1 study of mRNA-based combination vaccine for influenza and COVID-19.

By Region: Influenza Vaccines Market and Forecast - Key Takeaways

  • Geographically, North America is the largest market for influenza vaccines capturing over 50% share in 2024, owing to rising awareness of influenza viruses, high healthcare expenditure, and increasing research and development activities.
  • Europe captured second highest share of the global influenza vaccines market in 2024. In the European region, almost all countries have national and/or regional vaccination policies or strategies for seasonal influenza in place.
  • In United Kingdom, the flu vaccine coverage for people aged 65 years and over again remained higher than the target, resulting in four consecutive years of flu vaccine coverage at a standard espoused by the WHO. 
  • In the 2023/2024 season, the vaccine coverage in Denmark among elderly ≥65 years was estimated at 79%. 
  • Asia is expected to be the fastest growing market for influenza vaccines, driven by the increasing population in the Asian countries, growing focus of the governments on enhancing healthcare facilities, rising incidence of seasonal influenza, and rising disposable income.
  • Korea ranked highest in influenza vaccination rate in Asia at 311 vaccines per 1,000 people.
  • Indonesia has a low rate of influenza vaccination because immunization shots are expensive.

By Vaccine Type: Global Influenza Vaccines Market and Forecast - Key Takeaways

Inactivated vaccines held the largest market share of over 90% in 2024, and are anticipated to grow at the fastest rate over the forecast period.

The live attenuated influenza vaccines market is a growing segment within the global vaccine industry, primarily focused on vaccines designed to prevent influenza by using live, but weakened (attenuated), strains of the influenza virus.

By Indication: Global Influenza Vaccines Market and Forecast - Key Takeaways

The quadrivalent vaccines dominated the global influenza vaccines market in 2024, and is expected to grow at the fastest rate over the forecast period.  

The market for trivalent influenza vaccines is facing a decline in favor of quadrivalent influenza vaccines. Trivalent vaccines remain crucial in seasonal influenza vaccination programs, especially in areas with limited resources and vaccine access.

By Technology: Global Influenza Vaccines Market and Forecast - Key Takeaways

Egg-based vaccines accounted for highest share of the global influenza vaccines market in 2024. Egg-based vaccine production has been a longstanding and well-established method in the industry. Several vaccine manufacturers have invested heavily in egg-based infrastructure, making it a widely adopted and reliable production method. 

Cell-based influenza vaccines are an alternative to the traditional egg-based vaccines, offering several advantages in terms of speed, efficiency, and safety. 

By Route of Administration: Global Influenza Vaccines Market and Forecast - Key Takeaways

The injection segment held the largest market share in 2024. Healthcare payers prefer injection over nasal sprays due to better data on safety, efficacy, and cost-effectiveness with decades of use. 

Nasal spray influenza vaccines offer an alternative to injections, providing a non-invasive and needle-free administration option. The increasing adoption of nasal spray or intranasal vaccines at homecare settings, ease of self-administration, and ability of nasal spray to induce systemic as well as mucosal immunity drives the segment growth.

By End User: Global Influenza Vaccines Market and Forecast - Key Takeaways

Hospitals & pharmacies captured largest revenue share of over 50% in 2024. Hospitals & pharmacies are widely accessible to the general population. These healthcare settings benefit from established infrastructure along with the presence of trained healthcare professionals, collaboration with public health campaigns, and insurance coverage. 

Government & institutional supply is expected to be the fastest-growing segment over the coming years. Ongoing vaccination and immunization programs and the inclusion of influenza vaccines in vaccination programs worldwide are responsible for high growth of this segment.

Global Influenza Vaccines Market - Company Analysis

  • GSK’s influenza vaccines sales declined in 2024, driven by competitive pressure and volume phasing in the US and lower demand across other regions.
  • In 2023, Sanofi net sales of influenza vaccines declined by 10%, due to a slight reduction in vaccine uptake and increased competition in the United States. 
  • In December 2024, The US Food and Drug Administration has granted Fast Track designation to two Sanofi combination vaccine candidates to prevent influenza and COVID-19 infections in individuals 50 years of age and older.

This 388 Pages report with 172 Figures and 17 Tables has been analyzed from 13 viewpoints:

  • Global Influenza Vaccines Market, Persons Vaccinated and Forecast (2016 - 2032)
  • By Region - Influenza Vaccines Market, Persons Vaccinated and Forecast (2016 - 2032)
  • Country Wise Distribution - Influenza Vaccines Market, Persons Vaccinated and Forecast (2016 - 2032)   
  • By Vaccine Type - Global Influenza Vaccines Market and Forecast (2016 - 2032)
  • By Indication - Global Influenza Vaccines Market and Forecast (2016 - 2032)
  • By Technology - Global Influenza Vaccines Market and Forecast (2016 - 2032)
  • By Route of Administration - Global Influenza Vaccines Market and Forecast (2016 - 2032)
  • By End User - Global Influenza Vaccines Market and Forecast (2016 - 2032)
  • Influenza Vaccines Market - Key Company Analysis 
  • Influenza Vaccines Market - Emerging Players Profile
  • Global Influenza Vaccines Market - Major Deals
  • Global Influenza Vaccines Market - Recent Developments
  • Global Influenza Vaccines Market - Driving Factors and Challenges

By Region - Influenza Vaccines Market, Persons Vaccinated and Forecast

  • North America
  • Latin America
  • Europe
  • Asia
  • Australasia

Country Wise Distribution - Influenza Vaccines Market, Persons Vaccinated and Forecast

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Netherlands
  • Ireland
  • Denmark
  • Luxembourg
  • Sweden
  • Finland
  • Belgium
  • Poland
  • Norway
  • Australia
  • New Zealand
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Hong Kong
  • Malaysia
  • Thailand
  • Indonesia

By Vaccine Type - Global Influenza Vaccines Market and Forecast

  • Inactivated Influenza Vaccines
  • Live Attenuated Influenza Vaccines

By Indication - Global Influenza Vaccines Market and Forecast

  • Quadrivalent Influenza Vaccines
  • Trivalent Influenza Vaccines

By Technology - Global Influenza Vaccines Market and Forecast

  • Egg-based Influenza Vaccines
  • Cell-based Influenza Vaccines

By End User - Global Influenza Vaccines Market and Forecast

  • Hospitals & Pharmacies 
  • Government & Institutional Supply
  • Others

Influenza Vaccines Market - Key Company Analysis

  • GlaxoSmithKline (GSK)
  • Sanofi 
  • CSL Seqirus 
  • AstraZeneca 
  • Gamma Vaccines Pty Ltd.
  • Hualan Bioengineering Co., Ltd
  • Viatris Inc.
  • BioDiem Ltd 
  • Shanghai Institute of Biological Products Co., Ltd.

Influenza Vaccines Market - Emerging Players Profile

  • Novavax
  • Moderna Inc.
  • Pneumagen Ltd 
  • Daiichi-Sankyo
  • FluGen 
  • Imutex
  • EpiVax
  • Versatope Therapeutics, Inc.
  • BIKEN Co., Ltd.
  • Sinovac Biotech
  • Emergent BioSolutions
  • Osivax
  • Gylden Pharma Limited (Previously Emergex Vaccines)
  • Vir Biotechnology, Inc.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents


1. Executive Summary
2. Global - Influenza Vaccines Market and Forecast (2016 - 2032)
2.1 Global - Influenza Vaccines Market and Forecast
2.2 Global - Number of Persons Vaccinated with Influenza Vaccines and Forecast
3. Global - Influenza Vaccines Market Share and Forecast (2016 - 2032)
3.1 Influenza Vaccines Market Share and Forecast - Regional Analysis
3.2 Persons Vaccinated with Influenza Vaccines Share and Forecast - Regional Analysis
3.3 By Vaccine Type - Global Influenza Vaccines Market Share and Forecast
3.4 By Indication - Global Influenza Vaccines Market Share and Forecast
3.5 By Technology - Global Influenza Vaccines Market Share and Forecast
3.6 By Route of Administration - Global Influenza Vaccines Market Share and Forecast
3.7 By End User - Global Influenza Vaccines Market Share and Forecast
4. Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2016 - 2032)
4.1 North America - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.1.1 North America - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.1.2 North America - Influenza Vaccines Market and Forecast
4.2 Latin America - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.2.1 Latin America - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.2.2 Latin America - Influenza Vaccines Market and Forecast
4.3 Europe - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.3.1 Europe - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.3.2 Europe - Influenza Vaccines Market and Forecast
4.4 Asia - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.4.1 Asia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.4.2 Asia - Influenza Vaccines Market and Forecast
4.5 Australasia - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.5.1 Australasia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.5.2 Australasia - Influenza Vaccines Market and Forecast
5. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2016 - 2032)
5.1 United States - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.1.1 United States - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.1.2 United States - Influenza Vaccines Market and Forecast
5.2 Canada - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.2.1 Canada - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.2.2 Canada - Influenza Vaccines Market and Forecast
5.3 Brazil - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.3.1 Brazil - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.3.2 Brazil - Influenza Vaccines Market and Forecast
5.4 Mexico - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.4.1 Mexico - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.4.2 Mexico - Influenza Vaccines Market and Forecast
5.5 Germany - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.5.1 Germany - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.5.2 Germany - Influenza Vaccines Market and Forecast
5.6 France - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.6.1 France - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.6.2 France - Influenza Vaccines Market and Forecast
5.7 Italy - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.7.1 Italy - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.7.2 Italy - Influenza Vaccines Market and Forecast
5.8 Spain - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.8.1 Spain - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.8.2 Spain - Influenza Vaccines Market and Forecast
5.9 United Kingdom - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.9.1 United Kingdom - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.9.2 United Kingdom - Influenza Vaccines Market and Forecast
5.10 Netherlands - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.10.1 Netherlands - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.10.2 Netherlands - Influenza Vaccines Market and Forecast
5.11 Ireland - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.11.1 Ireland - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.11.2 Ireland - Influenza Vaccines Market and Forecast
5.12 Denmark - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.12.1 Denmark - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.12.2 Denmark - Influenza Vaccines Market and Forecast
5.13 Luxembourg - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.13.1 Luxembourg - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.13.2 Luxembourg - Influenza Vaccines Market and Forecast
5.14 Sweden - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.14.1 Sweden - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.14.2 Sweden - Influenza Vaccines Market and Forecast
5.15 Finland - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.15.1 Finland - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.15.2 Finland - Influenza Vaccines Market and Forecast
5.16 Belgium - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.16.1 Belgium - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.16.2 Belgium - Influenza Vaccines Market and Forecast
5.17 Poland - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.17.1 Poland - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.17.2 Poland - Influenza Vaccines Market and Forecast
5.18 Norway - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.18.1 Norway - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.18.2 Norway - Influenza Vaccines Market and Forecast
5.19 Australia - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.19.1 Australia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.19.2 Australia - Influenza Vaccines Market and Forecast
5.20 New Zealand - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.20.1 New Zealand - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.20.2 New Zealand - Influenza Vaccines Market and Forecast
5.21 Japan - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.21.1 Japan - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.21.2 Japan - Influenza Vaccines Market and Forecast
5.22 China - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.22.1 China - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.22.2 China - Influenza Vaccines Market and Forecast
5.23 India - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.23.1 India - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.23.2 India - Influenza Vaccines Market and Forecast
5.24 South Korea - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.24.1 South Korea - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.24.2 South Korea - Influenza Vaccines Market and Forecast
5.25 Thailand - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.25.1 Thailand - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.25.2 Thailand - Influenza Vaccines Market and Forecast
5.26 Singapore - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.26.1 Singapore - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.26.2 Singapore - Influenza Vaccines Market and Forecast
5.27 Hong Kong - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.27.1 Hong Kong - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.27.2 Hong Kong - Influenza Vaccines Market and Forecast
5.28 Malaysia - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.28.1 Malaysia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.28.2 Malaysia - Influenza Vaccines Market and Forecast
5.29 Indonesia - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.29.1 Indonesia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.29.2 Indonesia - Influenza Vaccines Market and Forecast
6. By Vaccine Type - Global Influenza Vaccines Market and Forecast (2016 - 2032)
6.1 Inactivated - Influenza Vaccines Market and Forecast
6.2 Live Attenuated - Influenza Vaccines Market and Forecast
7. By Indication - Global Influenza Vaccines Market and Forecast (2016 - 2032)
7.1 Quadrivalent - Influenza Vaccines Market and Forecast
7.2 Trivalent - Influenza Vaccines Market and Forecast
8. By Technology - Global Influenza Vaccines Market and Forecast (2016 - 2032)
8.1 Egg-based - Influenza Vaccines Market and Forecast
8.2 Cell-based - Influenza Vaccines Market and Forecast
9. By Route of Administration - Global Influenza Vaccines Market and Forecast (2016 - 2032)
9.1 Injection - Influenza Vaccines Market and Forecast
9.2 Nasal Spray - Influenza Vaccines Market and Forecast
10. By End User - Global Influenza Vaccines Market and Forecast (2016 - 2032)
10.1 Hospitals & Pharmacies - Influenza Vaccines Market and Forecast
10.2 Government & Institutional Supply - Influenza Vaccines Market and Forecast
10.3 Others - Influenza Vaccines Market and Forecast

11. Global Influenza Vaccines Market - Key Company Analysis
11.1 GlaxoSmithKline (GSK)
11.1.1 Business Overview
11.1.2 Influenza Vaccines Portfolio
11.1.3 Global - GSK Influenza Vaccines Sales and Forecast (2016 - 2032)
11.1.4 Promising Influenza Vaccines in Clinical Development
11.1.5 Recent Developments
11.2 Sanofi
11.2.1 Business Overview
11.2.2 Influenza Vaccines Portfolio
11.2.3 Global - Sanofi Influenza Vaccines Sales and Forecast (2016 - 2032)
11.2.4 Promising Influenza Vaccines in Clinical Development
11.2.5 Recent Developments
11.3 CSL Seqirus
11.3.1 Business Overview
11.3.2 Influenza Vaccines Portfolio
11.3.3 Global - CSL Seqirus Influenza Vaccines Sales and Forecast (2016 - 2032)
11.3.4 Promising Influenza Vaccines in Clinical Development
11.3.5 Recent Developments
11.4 AstraZeneca
11.4.1 Business Overview
11.4.2 Influenza Vaccines Portfolio
11.4.3 Global - AstraZeneca Influenza Vaccines Sales and Forecast (2016 - 2032)
11.4.4 Recent Developments
11.5 Gamma Vaccines Pty Ltd.
11.5.1 Business Overview
11.5.2 Influenza Vaccines Portfolio
11.5.3 Recent Developments
11.6 Hualan Bioengineering Co., Ltd.
11.6.1 Business Overview
11.6.2 Influenza Vaccines Portfolio
11.6.3 Recent Developments
11.7 Viatris Inc.
11.7.1 Business Overview
11.7.2 Influenza Vaccines Portfolio
11.7.3 Global - Viatris Influenza Vaccines Sales and Forecast (2021 - 2032)
11.8 BioDiem Ltd
11.8.1 Business Overview
11.8.2 Influenza Vaccines Portfolio
11.8.3 Recent Developments
11.9 Shanghai Institute of Biological Products Co., Ltd.
11.9.1 Business Overview
11.9.2 Influenza Vaccines Portfolio
12. Global Influenza Vaccines Market - Emerging Players Profile
12.1 Novavax
12.1.1 Business Overview
12.1.2 Promising Influenza Vaccines in Clinical Development
12.1.3 Recent Developments
12.2 Moderna Inc.
12.2.1 Business Overview
12.2.2 Promising Influenza Vaccines in Clinical Development
12.2.3 Recent Developments
12.3 Pneumagen Ltd
12.3.1 Business Overview
12.3.2 Promising Influenza Vaccines in Clinical Development
12.3.3 Recent Developments
12.4 Daiichi-Sankyo
12.4.1 Business Overview
12.4.2 Influenza Vaccines Portfolio
12.4.3 Recent Developments
12.5 FluGen
12.5.1 Business Overview
12.5.2 Promising Influenza Vaccines in Clinical Development
12.5.3 Recent Developments
12.6 Imutex
12.6.1 Business Overview
12.6.2 Promising Influenza Vaccines in Clinical Development
12.6.3 Recent Developments
12.7 EpiVax
12.7.1 Business Overview
12.7.2 Promising Influenza Vaccines in Clinical Development
12.7.3 Recent Developments
12.8 Versatope Therapeutics, Inc.
12.8.1 Business Overview
12.8.2 Promising Influenza Vaccines in Clinical Development
12.8.3 Recent Developments
12.9 BIKEN Co., Ltd.
12.9.1 Business Overview
12.9.1 Influenza Vaccines Portfolio
12.9.2 Recent Developments
12.10 Sinovac Biotech
12.10.1 Business Overview
12.10.2 Influenza Vaccines Portfolio
12.10.3 Recent Developments
12.11 Emergent BioSolutions
12.11.1 Business Overview
12.11.1 Promising Influenza Vaccines in Clinical Development
12.11.2 Recent Developments
12.12 Osivax
12.12.1 Business Overview
12.12.2 Promising Influenza Vaccines in Clinical Development
12.12.1 Recent Developments
12.13 Gylden Pharma Limited (Previously Emergex Vaccines)
12.13.1 Business Overview
12.13.2 Promising Influenza Vaccines in Clinical Development
12.13.3 Recent Developments
12.14 Vir Biotechnology, Inc.
12.14.1 Business Overview
12.14.2 Promising Influenza Vaccines in Clinical Development
12.14.3 Recent Developments
13. Global Influenza Vaccines Market - Major Deals
13.1 Mergers and Acquisitions
13.2 Licensing Agreements
13.3 Collaboration Agreements
14. Global Influenza Vaccines Market - Recent Developments
15. Global Influenza Vaccines Market - Driving Factors
16. Global Influenza Vaccines Market - Challenges
List of Figures
Figure 2-1: Global - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 2-2: Global - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 2-3: Global - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 2-4: Global - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 4-1: North America - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 4-2: North America - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 4-3: North America - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 4-4: North America - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 4-5: Latin America - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 4-6: Latin America - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 4-7: Latin America - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 4-8: Latin America - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 4-9: Europe - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 4-10: Europe - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 4-11: Europe - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 4-12: Europe - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 4-13: Asia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 4-14: Asia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 4-15: Asia - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 4-16: Asia - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 4-17: Australasia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 4-18: Australasia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 4-19: Australasia - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 4-20: Australasia - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-1: United States - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-2: United States - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-3: United States - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-4: United States - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-5: Canada - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-6: Canada - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-7: Canada - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-8: Canada - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-9: Brazil - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-10: Brazil - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-11: Brazil - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-12: Brazil - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-13: Mexico - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-14: Mexico - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-15: Mexico - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-16: Mexico - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-17: Germany - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-18: Germany - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-19: Germany - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-20: Germany - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-21: France - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-22: France - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-23: France - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-24: France - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-25: Italy - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-26: Italy - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-27: Italy - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-28: Italy - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-29: Spain - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-30: Spain - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-31: Spain - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-32: Spain - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-33: United Kingdom - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-34: United Kingdom - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-35: United Kingdom - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-36: United Kingdom - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-37: Netherlands - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-38: Netherlands - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-39: Netherlands - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-40: Netherlands - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-41: Ireland - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-42: Ireland - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-43: Ireland - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-44: Ireland - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-45: Denmark - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-46: Denmark - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-47: Denmark - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-48: Denmark - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-49: Luxembourg - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-50: Luxembourg - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-51: Luxembourg - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-52: Luxembourg - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-53: Sweden - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-54: Sweden - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-55: Sweden - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-56: Sweden - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-57: Finland - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-58: Finland - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-59: Finland - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-60: Finland - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-61: Belgium - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-62: Belgium - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-63: Belgium - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-64: Belgium - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-65: Poland - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-66: Poland - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-67: Poland - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-68: Poland - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-69: Norway - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-70: Norway - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-71: Norway - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-72: Norway - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-73: Australia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-74: Australia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-75: Australia - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-76: Australia - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-77: New Zealand - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-78: New Zealand - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-79: New Zealand - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-80: New Zealand - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-81: Japan - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-82: Japan - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-83: Japan - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-84: Japan - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-85: China - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-86: China - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-87: China - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-88: China - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-89: India - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-90: India - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-91: India - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-92: India - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-93: South Korea - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-94: South Korea - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-95: South Korea - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-96: South Korea - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-97: Thailand - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-98: Thailand - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-99: Thailand - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-100: Thailand - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-101: Singapore - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-102: Singapore - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-103: Singapore - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-104: Singapore - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-105: Hong Kong - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-106: Hong Kong - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-107: Hong Kong - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-108: Hong Kong - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-109: Malaysia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-110: Malaysia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-111: Malaysia - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-112: Malaysia - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 5-113: Indonesia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2024
Figure 5-114: Indonesia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2025 - 2032
Figure 5-115: Indonesia - Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 5-116: Indonesia - Forecast for Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 6-1: Global - Inactivated Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 6-2: Global - Forecast for Inactivated Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 6-3: Global - Live Attenuated Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 6-4: Global - Forecast for Live Attenuated Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 7-1: Global - Quadrivalent Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 7-2: Global - Forecast for Quadrivalent Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 7-3: Global - Trivalent Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 7-4: Global - Forecast for Trivalent Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 8-1: Global - Egg-based Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 8-2: Global - Forecast for Egg-based Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 8-3: Global - Cell-based Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 8-4: Global - Forecast for Cell-based Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 9-1: Global - Injection Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 9-2: Global - Forecast for Injection Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 9-3: Global - Nasal Spray Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 9-4: Global - Forecast for Nasal Spray Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 10-1: Global - Hospitals & Pharmacies Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 10-2: Global - Forecast for Hospitals & Pharmacies Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 10-3: Global - Government & Institutional Supply Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 10-4: Global - Forecast for Government & Institutional Supply Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 10-5: Global - Others Influenza Vaccines Market (Million US$), 2016 - 2024
Figure 10-6: Global - Forecast for Others Influenza Vaccines Market (Million US$), 2025 - 2032
Figure 11-1: Global - GSK plc Influenza Vaccines Sales (Million US$), 2016 - 2024e
Figure 11-2: Global - Forecast for GSK plc Influenza Vaccines Sales (Million US$), 2025 - 2032
Figure 11-3: Global - Sanofi Influenza Vaccines Sales (Million US$), 2016 - 2024e
Figure 11-4: Global - Forecast for Sanofi Influenza Vaccines Sales (Million US$), 2025 - 2032
Figure 11-5: Global - CSL Seqirus Influenza Vaccines Sales (Million US$), 2016 - 2024
Figure 11-6: Global - Forecast for CSL Seqirus Influenza Vaccines Sales (Million US$), 2025 - 2032
Figure 11-7: Global - AstraZeneca Influenza Vaccines Sales (Million US$), 2016 - 2024e
Figure 11-8: Global - Forecast for AstraZeneca Influenza Vaccines Sales (Million US$), 2025 - 2032
Figure 11-9: Global - Viatris Influenza Vaccines Sales (Million US$), 2021 - 2024e
Figure 11-10: Global - Forecast for Viatris Influenza Vaccines Sales (Million US$), 2025 - 2032

List of Tables
Table 3-1: By Region - Influenza Vaccines Market Share (Percent), 2016 - 2024
Table 3-2: By Region - Forecast for Influenza Vaccines Market Share (Percent), 2025 - 2032
Table 3-3: By Region - Persons Vaccinated with Influenza Vaccines Share (Percent), 2016 - 2024
Table 3-4: By Region - Forecast for Persons Vaccinated with Influenza Vaccines Share (Percent), 2025 - 2032
Table 3-5: By Vaccine Type - Influenza Vaccines Market Share (Percent), 2016 - 2024
Table 3-6: By Vaccine Type - Forecast for Influenza Vaccines Market Share (Percent), 2025 - 2032
Table 3-7: By Indication - Influenza Vaccines Market Share (Percent), 2016 - 2024
Table 3-8: By Indication - Forecast for Influenza Vaccines Market Share (Percent), 2025 - 2032
Table 3-9: By Technology - Influenza Vaccines Market Share (Percent), 2016 - 2024
Table 3-10: By Technology - Forecast for Influenza Vaccines Market Share (Percent), 2025 - 2032
Table 3-11: By Route of Administration - Influenza Vaccines Market Share (Percent), 2016 - 2024
Table 3-12: By Route of Administration - Forecast for Influenza Vaccines Market Share (Percent), 2025 - 2032
Table 3-13: By End User - Influenza Vaccines Market Share (Percent), 2016 - 2024
Table 3-14: By End User - Forecast for Influenza Vaccines Market Share (Percent), 2025 - 2032
Table 13-1: Global - Mergers and Acquisitions in Influenza Vaccines Market (Million US$), 2005 - 2022
Table 13-2: Global - Licensing Agreement in Influenza Vaccines Market (Million US$), 2007 - 2024
Table 13-3: Global - Collaboration Agreement in Influenza Vaccines Market (Million US$), 2019 - 2023

Companies Mentioned

  • GlaxoSmithKline (GSK)
  • Sanofi 
  • Seqirus (CSL Limited)
  • Abbott
  • AstraZeneca
  • Gamma Vaccines Pty Ltd.
  • Hualan Bioengineering Co., Ltd
  • Mylan (Now Part of Viatris)
  • BioDiem
  • Shanghai Institute of Biological Products Co., Ltd.
  • Novavax
  • Medicago
  • Moderna Inc.
  • Pneumagen
  • Daiichi–Sankyo
  • FluGen 
  • Imutex
  • EpiVax
  • Versatope Therapeutics, Inc.
  • BiondVax Pharmaceuticals Ltd.
  • BIKEN Co., Ltd.
  • Sinovac Biotech
  • Emergent BioSolutions
  • Osivax
  • Emergex Vaccines

Related Topics

Related Reports

Adult Vaccine Market Report, Forecast by Disease, Countries and Company Analysis, 2024-2032 - Product Image

Adult Vaccine Market Report, Forecast by Disease, Countries and Company Analysis, 2024-2032

  • Report
  • 200 Pages
  • Global
From
Influenza Vaccine Market Report by Vaccine Type, Technology, Age Group, Route of Administration, and Region 2024-2032 - Product Image

Influenza Vaccine Market Report by Vaccine Type, Technology, Age Group, Route of Administration, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
H1N1 Vaccines Market Report by Vaccine Type (Intramuscular, Intranasal, Intradermal), Market Type (Public, Private), and Region 2024-2032 - Product Image

H1N1 Vaccines Market Report by Vaccine Type (Intramuscular, Intranasal, Intradermal), Market Type (Public, Private), and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Microneedle Flu Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Microneedle Flu Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 117 Pages
  • Global
From
Influenza Vaccine Market by Vaccine Type, Age Group, Administration Route, Distribution Channel - Global Forecast 2025-2030 - Product Image

Influenza Vaccine Market by Vaccine Type, Age Group, Administration Route, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.